Skip to main content
. Author manuscript; available in PMC: 2011 Feb 5.
Published in final edited form as: J Proteome Res. 2010 Feb 5;9(2):945. doi: 10.1021/pr9008207

Figure 3.

Figure 3

YB-1 levels in bleomycin-treated cells overexpressing PP5 (H304Q) relative to cells overexpressing WT-PP5. HeLa cells expressing control or induced WT-PP5 or PP5(H304Q) were treated with bleomycin, then lysates prepared and subjected to western blot analysis for YB-1. GAPDH was monitored as the loading control. Western blot analyses were performed twice, with similar results.

HHS Vulnerability Disclosure